Skip to main content
    C

    Curis Inc (CRIS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.44
    -0.01 (-2.07%)

    Market Cap: $2.97M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Curis Inc (CRIS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Curis are PharmaCyte Biotech (PMCB), Traws Pharma (TRAW) and Calidi Biotherapeutics (CLDI). By market cap, Curis ranks 8th of the 13 companies on this page; CNS Pharmaceuticals (CNSP) is the largest at $4.22M.

    Peer Comparison

    CRIS's revenue growth of -66.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Curis (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Traws Pharma Inc (TRAW)$3.86MN/AN/A0.0%N/A-100.0%0.00%
    Calidi Biotherapeutics Inc. (CLDI)$2.29MN/AN/A0.0%N/A0.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    GRI Bio Inc. (GRI)$3.72MN/AN/A0.0%N/A0.0%0.00%
    Xenetic Biosciences Inc (XBIO)$3.89MN/A1.2x-75.9%N/A12.0%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    Onconetix Inc (ONCO)$2.15MN/A1.0x0.0%N/A-83.9%0.00%
    NuCana PLC (NCNA)$3.88MN/AN/A0.0%N/A0.0%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    Peer median$3.75MN/A1.1x0.0%-247.2%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Curis, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Traws Pharma Inc (TRAW)
    Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States.
    TRAW competitors
    Calidi Biotherapeutics Inc. (CLDI)
    Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer.
    CLDI competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    GRI Bio Inc. (GRI)
    GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology.
    GRI competitors
    Xenetic Biosciences Inc (XBIO)
    Xenetic Biosciences, Inc., a biopharmaceutical company, is focused on advancing XCART...
    XBIO competitors
    Ernexa Therapeutics Inc. (ERNA)
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors
    Onconetix Inc (ONCO)
    Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions.
    ONCO competitors
    NuCana PLC (NCNA)
    NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer.
    NCNA competitors
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors

    Frequently Asked Questions About CRIS

    Who are Curis' main competitors?

    The companies most similar to Curis include PharmaCyte Biotech (PMCB), Traws Pharma (TRAW), Calidi Biotherapeutics (CLDI), CNS Pharmaceuticals (CNSP) and GRI Bio (GRI), listed from the closest match.

    Who is Curis' biggest competitor?

    CNS Pharmaceuticals (CNSP) is the largest of the similar companies at $4.22M; PharmaCyte Biotech (PMCB) is the closest match by business profile, size, sector and industry.

    How does CRIS stock compare with its competitors?

    CRIS' P/S is 1.6x against a peer median of 1.1x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Curis' competitors pays a higher dividend?

    Curis pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Curis bigger than its competitors?

    No. Curis is 8th by market cap among the 13 companies on this page; the largest is CNS Pharmaceuticals (CNSP) at $4.22M.